{"title": "Find a Doctor", "author": null, "url": "https://www.dana-farber.org/find-a-doctor/matthew-b-yurgelun/", "hostname": "dana-farber.org", "description": "Matthew B. Yurgelun, MD - Medical Oncology.", "sitename": "Matthew B. Yurgelun, MD - Dana-Farber Cancer Institute", "date": "2018-02-07", "cleaned_text": "wasting precede clinical diagnosis of pancreatic cancer. Nat Commun. 2023 07 18; 14(1):4317. wild-type 18. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37463056) Serendipity Strikes: How Pursuing Novel Hypotheses Shifted the Paradigm Regarding the Genetic Basis of Colorectal Cancer and Changed Cancer Therapy. Dig Dis Sci. 2023 09; 68(9):3504-3513. View in: of FOLFIRINOX-induced neutropenia leads to systemic immune suppression in mice and humans. J Immunother Cancer. 2023 06; 11(6). View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/37344102) Expansion 2023 03 29; View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36989360) Clinical factors associated with skin neoplasms in individuals with Lynch syndrome in a longitudinal observational cohort. J Am Acad Dermatol. 2023 29(2):458-466. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36702949) MyLynch: A Patient-Facing Clinical Decision Support Tool for Genetically-Guided Personalized Medicine in Lynch Syndrome. Cancers (Basel). 2023 Jan 06; 15(2). View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36672340) Programmatic Precision Oncology 21(3):581-603.e33. Med. 2022 11 03; 387(18):1714-1716. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36322852) An updated counseling approach to aid interpretation of germline variants of uncertain significance in cancer susceptibility genes. Front Oncol. 2022; 12:942741. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36091175) Development and Validation of the PREMMplus Model for Multigene Hereditary Cancer Risk 2022 12 40(35):4083-4094. View Germline Testing in Pancreatic 15(3):491-502. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/36049831) More Than 20 Years of Progress in Pancreatic Cancer Surveillance for High-Risk Individuals. J 01; 40(28):3230-3234. It Time for Universal Germline Genetic Testing for All GI Cancers? 08 20; BRCA1, and PALB2 in adults with metastatic gastrointestinal cancer: a pilot and feasibility study. 2022; 8(2):e001353. 27(4):292-298. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/35380713) Risk assessment and genetic counseling for Lynch syndrome - Practice resource of the National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Gastrointestinal in: Imaging in Individuals at High Risk for Pancreatic Cancer: Not a Ceiling, but Rather a Floor Upon Which to Build. Gastroenterology. 2022 03; 162(3):700-702. View in: in a platinum-sensitive, BRCA2-mutated pancreatic cancer patient after earlier progression on placebo treatment on the POLO trial: a case report. J Gastrointest Oncol. Cancer in of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study. 2021 11; Editor-Recent advances in Lynch syndrome: response to M\u00f8ller Cancer. View Letter Editor-Recent in Lynch syndrome: to M\u00f8ller View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32743791) Familial Burden and Other Clinical Factors Associated With Various Types of Cancer in Individuals With Lynch Syndrome. Gastroenterology. 2021 07; 161(1):143-150.e4. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33794268) A Case-Based Approach to Understanding Complex Genetic Information in an Evolving Landscape. Am Soc Clin Oncol Educ Book. 2021 Mar; 41:1-11. cancer risk syndrome: controversies recommendations. Fam Cancer. 2022 01; 21(1):75-78. [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33611683) Implementing Systematic Counseling Standard-Dose Vitamin D3 Supplementation on Body Composition among Patients with Advanced or Metastatic Colorectal Cancer: A Randomized Trial. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/33233566) Phenotypic Differences in Juvenile Polyposis With or SMAD4/BMPR1A Microsatellite Instability Tumor Analysis and Premm5 Risk Assessment for Predicting Pathogenic Germline Variants on Multigene Panel Testing. 04; 20(2):111-116. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32743790) Collaborative Group of the Americas on Inherited Gastrointestinal Cancer Position statement on multigene panel testing for patients with colorectal cancer and/or polyposis. Fam Cancer. 2020 07; 19(3):223-239. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32172433) Aspirin for Lynch syndrome: a of Therapy-Associated Polyposis in Childhood and Young Adulthood Cancer Survivors. Cancer Prev Res (Phila). 2020 03; 13(3):291-298. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/32051178) Correction to: Health Care Provider Perceptions of Caring for Individuals with Inherited Pancreatic Cancer Risk. J Cancer Educ. 2020 Feb; 35(1):204. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31848936) Identification of Lynch syndrome by microsatellite instability and mismatch repair deficiency testing on colorectal adenomas. Eur J Hum Genet. 2020 03; 28(3):275-276. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31857714) Clinical Factors Associated with Urinary Tract Cancer in Individuals with Lynch Syndrome. Cancer Epidemiol Biomarkers Prev. 2020 01; 29(1):193-199. Fam Cancer. 2019 10; 18(4):457-464. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/31522335) Clinical Factors Associated With Gastric Cancer in Individuals With Lynch Syndrome. Clin Gastroenterol Hepatol. Sequencing as a Primary Screening Tool for Microsatellite Instability and Lynch Syndrome in Upper Gastrointestinal Tract Cancers. Epidemiol Biomarkers D3 Supplementation Survival Among With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized 09; 321(14):1370-1379. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30964527) Recent advances 18(2):211-219. View 07 01; 125(13):2213-2221. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30913304) Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk. Br J Cancer. 2019 04; 120(8):848-854. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30867564) Multigene panel for inherited cancer risk: 'a somewhat Per Med. 2019 03; [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30741585) 156(7):2041-2055. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30660730) Tumor Testing for Microsatellite Instability to Identify Lynch Syndrome: New Insights Into an Old Diagnostic Strategy. J Clin Oncol. 2019 02 01; 37(2):153-164. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30457921) A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma. Clin Cancer Res. 2019 01 01; [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/30190369) Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer. Genet Med. 2019 of a targeted next-generation approach to detect mismatch repair deficiency in Mod Pathol. 2018 12; 31(12):1882-1890. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29955144) Precision Prevention and Early Detection of Cancer: Fundamental Discov. 2018 07; Real-time Genomic Characterization Advanced to Medicine. Cancer Discov. 2018 09; 8(9):1096-1111. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29903880) Recent Advances in Lynch Syndrome: Diagnosis, Treatment, and Cancer Prevention. Am Soc Clin Oncol Educ Book. 2018 May 23; counseling framework for Genet Med. 2018 11; 20(11):1324-1327. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29493579) Recent progress in Lynch syndrome and other familial colorectal cancer syndromes. CA Cancer in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29485237) Inherited DNA-Repair 2018 03 01; 102(3):401-414. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29478780) The Role of Genetic Counseling in Familial and Sporadic Cancer: Considerations, Challenges, and Collaboration. Ann Intern Med. 2017 12 19; 167(12):884-885. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/29086794) Germline Testing for Individuals With Pancreatic Cancer: The Benefits and Challenges to Casting a Wider Net. J Clin Oncol. 2017 10 20; 35(30):3375-3377. View in: Implementation of a Self-administered Version of PREMM1,2,6 to Assess Risk for Lynch Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome. J Oncol. 2017 Jul 01; 35(19):2165-2172. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28489507) Precision Cancer Res. 2017 04 01; 77(7):1510-1541. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28373404) Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome. Int J Gynecol Pathol. biomarker study of cabozantinib patients with View in: Cell. 2017 02 09; 168(4):566-570. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/28187278) Cancer Susceptibility Gene in Colorectal Microsatellite Instability prevention. Proc Acad Sci S in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/27638202) Genetic predisposition View 2015 Oct 01; 33(28):3092-5. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26282646) Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome. Gastroenterology. 2015 Sep; 149(3):604-13.e20. View Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family 2015 May; 1(2):214-21. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/26086041) Oncol. 2015 Feb 10; View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/25559814) metastatic biliary tract 29; 111(3):430-6. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/24960403) Therapy-associated 2014 Jun; genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch Gynecol Oncol. 2012 Dec; 127(3):544-51. View in: [PubMed](http://www.ncbi.nlm.nih.gov/pubmed/22940489) Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps. Cancer Prev Res (Phila). 2012 Apr; by stromal cell derived factor-1 (SDF-1) in giant cell tumor of bone. J "}